Stratos Wealth Partners, Ltd. Galapagos Nv Transaction History

Stratos Wealth Partners, Ltd.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Feb 08, 2019	SELL	$87.81 - $110.65 $30,733 - $38,727	-350 Closed	0 $0
Q3 2018 Nov 02, 2018	BUY	$90.63 - $120.22 $31,720 - $42,077	350 New	350 $39,000
Q2 2018 Aug 13, 2018	SELL	$88.4 - $105.34 $30,940 - $36,869	-350 Closed	0 $0
Q1 2018 May 10, 2018	BUY	$94.51 - $120.23 $33,078 - $42,080	350 New	350 $35,000

12.3M

69.1K

42.7K

Ticker GLPG
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 65,835,500
Market Cap $1.9B
Description
Galapagos NV, an integrated biopharmaceutical company, engages in the discovery, development, and commercialization of various medicines for high unmet medical need. Its pipeline products include filgotinib, a JAK1 inhibitor that is in various phases of clinical trials for the treatment of rheumatoid arthritis, Crohn's disease, ulcerative coliti...

Get notified when there are updates to the investment portfolio of Stratos Wealth Partners, Ltd., based on Form 13F filings with the SEC.

Stay updated on Stratos Wealth Partners, Ltd. with notifications on news.